Provis Biolabs
CAS No.9025-24-5
Carboxypeptidase B Cleavage Diagram

Carboxypeptidase B

Recombinant C-Terminal Cleavage Enzyme for Biologics & Insulin

Recombinant C-Terminal Cleavage Enzyme for Biologics & Insulin

Carboxypeptidase B is a highly specific exopeptidase utilized in the maturation of recombinant proteins, insulin processing, and the removal of C-terminal lysine residues in monoclonal antibodies.

A meticulously expressed recombinant serine protease, Carboxypeptidase B selectively targets the rapid and exact cleavage of basic amino acid terminals (Arginine, Lysine). It is globally deployed across high-yielding industrial purification processes most notably in recombinant insulin processing where uncompromised enzyme specificity and scalable, consistent downstream capabilities are non-negotiable.


Key Features

Validated for Insulin & Biosimilar Manufacturing
IEX-Compatible for Downstream Processing
High Purity >99% by SDS-PAGE
High Specific Activity Pharmacopoeial Grade

Applications

BioprocessingProtein CharacterizationInsulin Manufacturing